Back to Journals » Open Access Journal of Contraception » Volume 5

New and emerging contraceptive options: a focus on transdermal contraception

Authors Böttcher B, Wildt L

Received 6 November 2013

Accepted for publication 30 November 2013

Published 8 January 2014 Volume 2014:5 Pages 1—5


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Bettina Böttcher, Ludwig Wildt

Department of Gynecologic Endocrinology and Reproductive Medicine, Innsbruck Medical University, Innsbruck, Austria

Abstract: Transdermal contraception is a convenient way of hormonal contraception that allows weekly application of a patch for 3 consecutive weeks followed by a patch-free week. Efficacy, side effects, advantages, and disadvantages as well as patient satisfaction with this formulation are discussed in this short review. The first patch, introduced in 2002, contained ethinylestradiol and norelgestromin. Recently, a new patch containing gestodene as the gestagen component has been developed. Early data for this formulation are presented.

Keywords: transdermal contraception, skin patch

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]